| Revenue Information |
Note 11 – Revenue Information
Revenue by product lines was
as follows:
| |
|
|
Three months ended |
|
|
Six months ended |
|
| |
|
|
June 30, |
|
|
June 30, |
|
| Product Line |
|
|
2018 |
|
|
2017 |
|
|
2018 |
|
|
2017 |
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
| MicroParticle Catalyzed Biosensor (“MPC”) |
|
|
$ |
106,680 |
|
|
$ |
69,848 |
|
|
$ |
125,630 |
|
|
$ |
155,507 |
|
| Particle ImmunoFiltration Assay (“PIFA”) |
|
|
|
356,082 |
|
|
|
426,747 |
|
|
|
616,066 |
|
|
|
987,668 |
|
| Rapid Enzymatic Assay (“REA”) |
|
|
|
45,100 |
|
|
|
- |
|
|
|
55,000 |
|
|
|
- |
|
| Other |
|
|
|
18,739 |
|
|
|
576,266 |
|
|
|
32,380 |
|
|
|
596,936 |
|
| Total Revenue |
|
|
$ |
526,601 |
|
|
$ |
1,072,861 |
|
|
$ |
829,076 |
|
|
$ |
1,740,111 |
|
The total revenue by geographic
area determined based on the location of the customers was as follows:
| |
|
Three Months Ended |
|
|
Six Months Ended |
|
| |
|
June 30, |
|
|
June 30, |
|
| Geographic Region |
|
2018 |
|
|
2017 |
|
|
2018 |
|
|
2017 |
|
| United States |
|
$ |
462,383 |
|
|
$ |
512,257 |
|
|
$ |
757,116 |
|
|
$ |
1,129,482 |
|
| People’s Republic of China |
|
|
- |
|
|
|
478,205 |
|
|
|
- |
|
|
|
502,268 |
|
| Rest of World |
|
|
64,218 |
|
|
|
82,399 |
|
|
|
71,960 |
|
|
|
108,361 |
|
| Total Revenue |
|
$ |
526,601 |
|
|
$ |
1,072,861 |
|
|
$ |
829,076 |
|
|
$ |
1,740,111 |
|
The Company had long-lived
assets totaling $66,847 and $59,830 located in the People’s Republic of China and $1,223,728 and $1,305,950 located in the
United States as of June 30, 2018 and December 31, 2017, respectively.
|